Electromed Resumes Study of SmartVest

Electromed Resumes Study of SmartVest

286280

Electromed Resumes Study of SmartVest

Electromed has resumed a study seeking to assess the effects of SmartVest, an inflatable vest that can be used to deliver high-frequency chest wall oscillation (HFCWO) therapy, on the quality of life of patients with bronchiectasis. The study (NCT04271969) was paused last year due to safety concerns posed by the COVID-19 pandemic. However, according to the company, the study has now been given a green light to resume at four sites across the U.S. More…

You must be logged in to read/download the full post.